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Abstract
Whole-exome or gene targeted resequencing in hundreds to thousands of individuals has shown that the majority of
genetic variants are at low frequency in human populations. Rare variants are enriched for functional mutations and are
expected to explain an important fraction of the genetic etiology of human disease, therefore having a potential medical
interest. In this work, we analyze the whole-exome sequences of French-Canadian individuals, a founder population with a
unique demographic history that includes an original population bottleneck less than 20 generations ago, followed by a
demographic explosion, and the whole exomes of French individuals sampled from France. We show that in less than 20
generations of genetic isolation from the French population, the genetic pool of French-Canadians shows reduced levels of
diversity, higher homozygosity, and an excess of rare variants with low variant sharing with Europeans. Furthermore, the
French-Canadian population contains a larger proportion of putatively damaging functional variants, which could partially
explain the increased incidence of genetic disease in the province. Our results highlight the impact of population
demography on genetic fitness and the contribution of rare variants to the human genetic variation landscape, emphasizing
the need for deep cataloguing of genetic variants by resequencing worldwide human populations in order to truly assess
disease risk.
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Introduction
Genetic variation in humans is a result of stochastic processes,
selection and demographic history [1]. Modern humans show a
reduced level of differentiation due to recent population dispersion
less than 100,000 years ago, and differences between populations
are thought to account for little more than 15% of all genetic
variation across individuals [2]. However, this picture is based on
the allele frequency differences of common and shared variants
between populations, representing only a small fraction of the total
number of variants. Recently, much effort has been put into the
description of the total variation landscape in human populations
by resequencing hundreds to thousands of individuals from the
same population at particular loci or for complete exomes [3–8].
Additionally, the 1000 Genomes Project has characterized the
complete genomic sequences of more than one thousand humans
covering worldwide diversity [9,10].
Two important conclusions have arisen from studies deeply
characterizing the allele frequency spectrum in human popula-
tions. First, the high number of low frequency variants is likely
only explainable by models of recent demographic explosion [3–
8]. Furthermore, low frequency variants are enriched for
functional variants, particularly for nucleotide changes that affect
protein function, and are therefore putatively more related to
disease [3–8,11]. Second, most rare variants are private or show
very little sharing among continents [7,8,12,13]. This may be
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particularly important in terms of genetic fitness, since rare
variants are enriched for deleterious alleles. However, until now
differences in the relative amount of detrimental variants have
only been shown over relatively large timescales by comparing
African and European populations [14,15]. Furthermore, these
findings predict a lack of replication in association studies using
rare functional variants across populations, since rare variants can
show higher levels of stratification [16], thus emphasizing the need
of population-specific catalogues of genetic variation [12].
In this work, we analyze whole-exome sequence data from
French-Canadian individuals, comparing various population level
statistics to those for French and European populations, which allow
us to make inferences about the fitness of a population with a unique
demographic history. The current population of six million French-
Canadians in Quebec are descendants of about 8,500 French
settlers who colonized the province between 1608 and 1759, before
the English conquest [17,18]. Although colonization included
emigrants from all of France, the migration event mostly originated
from the Atlantic coast and Paris region. After 1760, French
immigration virtually stopped, and the French-Canadian popula-
tion experienced rapid growth due to a high birth rate, and became
genetically isolated from France with limited exchange with other
non-French communities in the same geographical area [19].
Overall, French-Canadians have experienced a growth from 8,500
to six million individuals, which represents a population expansion
of more 700% in less than 20 generations. While other colonized
territories in America or Oceania may have experienced a similar
growth, the uniqueness of the French-Canadian population is due in
part to the reduced contribution of new immigration after the first
settlers [20] and the founding population is estimated to have
contributed 90% of the current French-Canadian genetic pool [21].
In addition, during the 19th century new territories were colonized
by a reduced number of settlers, contributing massively to the
genetic pool in these regions, giving place to several regional
founder effects. This particular component of the demographic
history of the French-Canadian population has resulted in a
geographic heterogeneity of genetic diseases in Quebec, with more
than twenty Mendelian diseases occurring at unexpectedly high
frequencies in some areas of the province [19,22].
Here, we specifically test the theory that deleterious mutations
accumulate and/or persist in a population that has undergone a
demographic bottleneck and rapid expansion in a short period of
time, potentially as a consequence of reduced selection, using the
French-Canadian population of Quebec. It has been argued that
colonists at the forefront of expansions have a fitness advantage
[23]. Here we show that if this is the case, then this short-term
fitness advantage may come at an overall long-term cost. We also
aim to describe how this complex demographic scenario has
shaped the genetic variation in a modern population; as of yet, no
study has described how the original genetic bottleneck and
subsequent population expansion have affected the full-spectrum
of genetic variation among French-Canadians.
Results
Through exome-sequencing, we set out to determine how the
distribution of variants in a founder population differs both in
overall frequency, and potential functional impact relative to the
source or progenitor population. All major observations were
replicated on two different sequencing platforms and with similar
sample sizes (see Material and Methods and results below). In
total, we detect 64,631 high-quality SNPs in 109 individuals from
the French-Canadian population with low error rates (see Material
and Methods). Using previously described data [24], we find a
total of 46,662 high-quality SNPs from 30 individuals in the
French population. The difference in the number of SNPs
detected is largely driven by the different sample sizes. The
numbers of SNPs falling into each functional category are shown
in Table S1. Compared to French individuals, French-Canadians
have lower levels of heterozygosity (on average 19.2% and 11.5%
of the variants per individual are heterozygous in French and
French-Canadians, respectively) and have lower average nucleo-
tide pairwise diversity (Table 1). Reduced genetic diversity in the
French-Canadian population is consistent with the historically
documented population bottleneck.
The French-Canadian population also exhibits an excess of low
frequency variants in comparison to the French population
(Figure 1), and the proportion of variants with MAF,5% is
significantly higher in the French-Canadian population (p,0.01).
The excess is not a consequence of different sample sizes; if we
resample the same number of individuals from each population
and include only sites where all individuals pass identical quality
filters, we observe a similar excess of rare variants in the French-
Canadian population compared to the French population (Figure
S1). The distribution of allele frequencies is likely indicative of the
population expansion undergone by French-Canadians after the
bottleneck out of Europe and is supported by lower per locus
Tajima’s D values (Table 1) when compared to the French
population (t-test p value = 6.51e-15) (Figure S2). As seen in
previous studies, low frequency classes are enriched for nonsense
and missense variants in relation to synonymous variants (Figure
S3). Strikingly, among the total number of SNPs, only a relatively
small fraction (36.5%) are shared between the two populations
(Figure S4) and this fraction decreases for functional SNPs
(missense, nonsense, splice site), which are enriched for rare
variants. When considering those variants shared between
populations, we find a high level of agreement; of the 29,767
variants shared by both populations, the vast majority have
extremely low FST scores (97.6% are less than 0.05), indicating
little population differentiation for most common variants.
In order to compare the French-Canadian SNPs to a larger
dataset, we extended the comparison to a list of variants
discovered from high-coverage sequencing of exomes in 85 CEU
Author Summary
Recent resequencing of the whole genome or the coding
part of the genome (the exome) in thousands of
individuals has described a large excess of low frequency
variants in humans, probably arising as a consequence of
recent rapid growth in human population sizes. Most rare
variants are private to specific populations and are
enriched for functional mutations, thus potentially having
some medical relevance. In this study, we analyze whole-
exome sequences from over a hundred individuals from
the French-Canadian population, which was founded less
than 400 years ago by about 8,500 French settlers who
colonized the province between the 17th and 18th
centuries. We show that in a remarkably short period of
time this population has accumulated substantial differ-
ences, including an excess of rare, functional and
potentially damaging variants, when compared to the
original European population. Our results show the effects
of population history on genetic variation that may have
an impact on genetic fitness and disease, and have
implications in the design of genetic studies, highlighting
the importance of extending deep resequencing to
worldwide human populations.
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individuals in the 1000 Genomes Project [9], as well as 1,007
individuals from other populations from the same resource, and
find that the French-Canadian population shows a high percent-
age of private variants not found in any other population (Table 2).
The distribution of these non-shared variants is asymmetric, and is
enriched for rare and missense variants. The proportion of private
variants is lower than those reported in comparisons across
different continents, but higher than proportions observed across
populations in the same continent [12,13]. Roughly, populations
in different continents share only about 10% of rare variants, while
close populations in the same continent, such as individuals from
the CEU and Tuscany (Italy) populations, share about 90% of rare
variants [7,8,12,13].
Given that we observe an excess of rare variants at functional
sites in the French-Canadian population, we consider the effect of
these variants on fitness and selection using a number of different
approaches. First, we test for differences in the ratio of missense to
synonymous changes within the SFS (Figure 2). Whilst the
missense to synonymous ratio in the French population for SNPs
with MAF,5% (1.31) is very similar to that observed in other
populations [11], the French-Canadian ratio of 1.47, points to a
major fraction of deleterious SNPs in the population, which carries
a significantly larger proportion of rare mutations at missense sites
(p,0.01, chi-squared test). For the most common variants
(MAF.0.25), the French and French-Canadian populations have
identical missense to synonymous ratios (0.77). Second, we
consider the predicted effects of nonsynonymous variants using
GERP scores [25] and find more evidence for an excess of
potentially damaging mutations in the French-Canadian popula-
tion. GERP is a measure of conservation that is calculated across
34 mammalian species [25] and since it inversely correlates with
derived allele frequency (DAF) [26,27], it can be used to classify
genetic variants and is often used as part of a criteria to prioritize
functional variants in disease studies [28]. Comparing missense
and nonsense SNPs in the French and French-Canadian
populations, we find that the average GERP score is significantly
higher for mutations in the French-Canadian population (Wil-
coxon signed-rank test, p = 0.004). The difference is particularly
strong for SNPs at the lowest frequencies (Figure 2), which are
enriched for mutations with a higher impact on protein function,
but the average GERP score for variants with MAF.10% is also
significantly higher in the French-Canadian population (p,0.01).
Conversely, we do not observe significant differences between
populations when synonymous changes are compared (Wilcoxon
signed-rank test, p = 0.846). The same enrichment for higher
GERP scores in the French-Canadian population is also seen
when comparing the distribution of average GERP scores for
alleles carried at missense sites within each individual (Figure 2),
and overall French-Canadian individuals have significantly higher
mean GERP scores than French Individuals (Wilcox-rank sum
test, p,0.001). Third, a significantly higher proportion of missense
variants are predicted to be damaging in the French-Canadians
compared to the French population using Polyphen [29] (49.5%
and 45.5% respectively, p,0.01), indicating that on average
variants segregating in the French-Canadian population tend to be
putatively more damaging.
The inference of a higher proportion of deleterious alleles in the
French-Canadian population is not a consequence of different
sample sizes; resampling thirty individuals from the French-
Canadian population, we again find a significantly larger missense
to synonymous ratio for rare alleles (1.44, p,0.01), a significantly
higher average GERP score for rare alleles at missense sites (2.194
Table 1. Population genetic measures in the 38 Mb targeted regions for the French and the French-Canadian populations.
Sample size Coding SNPs *hW (610
24) p (61024) D{ Het`
French 30 32,187 3.50 2.97 20.14 19.2%
French-Canadian 109 44,485 2.77 1.81 20.41 11.5%
*Watterson’s estimate.
{Tajima’s D, calculated as an average across genes with five or more segregating sites.
`Heterozygosity, calculated as the percentage of heterozygous variants per individual at variant sites.
doi:10.1371/journal.pgen.1003815.t001
Figure 1. Site frequency spectrum in the French and French-Canadian populations. A) Joint frequency spectrum of genetic variation
between the French (FR) and the French-Canadian (FC) populations, projected to 50 samples per population; B) Site frequency spectrum in the
French and the French-Canadian population for the synonymous variants using derived allele frequency; C) Site frequency spectrum in the French
and the French-Canadian population for the missense variants using derived allele frequency.
doi:10.1371/journal.pgen.1003815.g001
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for resampled French-Canadians, 2.067 for French, p,0.01) and a
significantly larger proportion of missense variants predicted to be
damaging by Polyphen (49.6%, p,0.01) for French-Canadians
when compared to the French population. Furthermore, it is
unlikely that the excess of rare deleterious alleles in French-
Canadians is driven by data quality since we estimate a false
positive rate of ,0.2% for singletons (see Material and Methods),
which are most likely to be enriched for error.
To understand why there is an excess of putative damaging
variants in the French-Canadian population, we analyzed the
intensity of natural selection in both the French and French-
Canadian populations. First, we estimated the demographic
parameters and the population selection parameter (c=Ne(s))
using the Poisson Random Fields method implemented in prfreq
[14]. To estimate population demographic parameters, we used
synonymous sites to test different demographic models and we find
a significantly better fit for models that include a bottleneck and
expansion compared to neutral stationary models for both the
French and the French-Canadian populations (Tables S2 and S3,
Kolmogorov-Smirnov (KS) tests, p.0.05 in both cases). Although
these models are necessarily simplified to capture key demographic
processes rather than a literal history of the populations, we used
them as a correction factor when next attempting to infer selection
parameters at nonsynonymous sites. To this end, models including
both the three-parameter demographic history and negative
selection have a significantly better fit to the observed site
frequency spectrums for both the French and French-Canadian
populations at nonsynonymous sites than models assuming
neutrality or including demographic history alone (Tables S2
and S3 and Figure S5, p,0.001). As expected, including selection
does not significantly improve the fit to the site frequency spectrum
at synonymous sites, which provides a good check on the
demographic model. The estimated c parameter in French-
Canadians is substantially less negative than that in the French
population (c=2115 in French population, c=282 in French-
Canadian population, p,0.001), which could be at least partially a
result of smaller Ne in the French-Canadian population.
Second, we estimated the distribution of fitness effects (DFE) of
mutations segregating in French and French-Canadian popula-
tions using the DFE-alpha software (http://homepages.ed.ac.uk/
eang33/), which predicts the effects of new deleterious mutations
using the site frequency spectrum [30]. The DFE estimated for the
French population is broadly similar to that predicted for the
European population in a previous study [31] using the two epoch
model (Table 3), and the mean selective effect (Ne(s)) is similar to
the c value predicted by prfreq. Interestingly, the DFE estimated for
the French-Canadian population has a much lower mean selective
effect for new deleterious mutations of 12.8 (compared to 104.9 for
Table 2. Shared SNPs between the French-Canadian population and the 1000 Genomes Project populations.
Rare (MAF#2%) Rare (MAF#5%) Common (MAF$20%) Total
Total SNPs 30,193 39,323 12,223 64,630
CEU population (%) 37% 47% 99% 67%
All populations (%) 62% 68% 99% 80%
Nonsynonymous SNPs 13,541 16,760 3,453 24,418
CEU population (%) 33% 41% 98% 58%
All populations (%) 56% 61% 98% 72%
Synonymous SNPs 8,477 11,403 4,368 20,067
CEU population (%) 40% 52% 99% 72%
All populations (%) 67% 73% 99% 84%
doi:10.1371/journal.pgen.1003815.t002
Figure 2. Excess of functional variants in the French-Canadian population. A) Ratio of nonsynonymous to synonymous changes in the French
and the French-Canadian populations for variants grouped byminor allele frequency. B) Average GERP value of the functional changes for each frequency
class in the French and the French-Canadian populations. C) Distributions of the average GERP scores at functional sites per individual in the French and
the French-Canadian populations. GERP scores are averaged per individual by using only sites at which each individual carries the minor allele.
doi:10.1371/journal.pgen.1003815.g002
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the French population). Furthermore, the proportion of strongly
selected deleterious mutations is much lower in the French-
Canadian population compared to the French (Table 3), which
could reflect a relaxation of selection in the French-Canadian
population due either to a reduction in Ne or the new
environment, that has subsequently led to an accumulation or
the persistence of potentially harmful rare variants.
Finally, to test whether the differences we observe between the
two populations are driven by different sequencing platforms, we
analyzed data from an additional 50 French-Canadian individuals
sequenced on Illumina’s HiSeq platform and compared the results
to the French dataset; we replicate all of the major findings. First,
we observe a significant excess of rare variants in the French-
Canadian Illumina dataset compared to the French (57.4% and
45.3% of variants with MAF#5% respectively, p,0.01, Figure
S6, Table S4). Similarly, comparing datasets sequenced on the
SOLiD platform by considering a further European dataset (CEU
population from the 1000 Genomes Project), we again find an
excess of rare variants in the French-Canadian population
(p,0.01, Figure S6). Second, we find a significantly larger
missense to synonymous ratio for rare alleles (1.39, p,0.01,
Table S4) and a significantly larger proportion of missense variants
predicted to be damaging by Polyphen (48.2%, p,0.01, Table S4)
for the French-Canadian Illumina dataset compared to the
French. Finally, rare alleles at missense sites have a significantly
larger GERP score on average in the French-Canadian Illumina
data (2.194, p,0.01, Table S4) when compared to the French
population and when considering the distribution of average
GERP scores at missense sites within these individuals, French-
Canadians have significantly higher mean GERP scores than
French Individuals (p,0.01, Figure S7).
Discussion
Recent deep resequencing of human populations has highlight-
ed an accumulation of rare variants above that expected under
Wright-Fisher models [3–8]. Using exome resequencing data from
over a hundred French-Canadian individuals, we show that a
human founding population that has undergone rapid expansion
contains an excess of private and rare variants compared to the
French population after a colonization event less than 20
generations ago. Genetic variants in French-Canadians tend to
be putatively more deleterious than those in the French. On the
population level, evidence for this comes from the fact that
mutations in the French-Canadian population tend to occur at
functional sites with higher conservation scores and/or sites
predicted to be damaging, are located preferentially at missense
sites, and have higher missense to synonymous ratios than in
French and European populations. Furthermore, at the individual
level, this potentially translates into an increased genetic burden,
since although French-Canadians carry a similar number of
derived alleles as the French, these alleles tend to occur at more
putatively damaging sites, as indicated by alleles in French-
Canadians occurring at sites that on average have higher GERP
scores (Figure 1C). Furthermore, since the French-Canadian
population shows lower levels of heterozygosity (and thus higher
levels of homozygosity), this may have implications for disease
susceptibility.
It is known that the incidence of around twenty Mendelian
diseases is higher in Quebec [19,22] and some hereditary diseases
show a particular pattern in the French-Canadian population,
with local enrichments within particular geographical areas
originated by regional founder effects [19,22,32]. Although it is
difficult to translate our results into specific population genetic risk
estimates, it may be possible that the increase of rare deleterious
variants and reduced heterozygosity in the French-Canadian
population is leading to higher disease risk. Rare alleles that were
present at damaging sites in the original population may
subsequently have been removed in the French population, yet
still persist in French-Canadian individuals due to sampling effects,
smaller population sizes, less competition and a higher birth rate.
Although this seems unlikely to impact upon diseases caused by
recessive variants in homozygous form, damaging mutations that
have arisen since the founder event may be dominant or serve as
the second, and ultimately vital, mutation within an important
gene under a compound heterozygous model of Mendelian
disorders. Furthermore, we find some evidence that higher
frequency variants (MAF.10%) are on average more damaging
in the French-Canadian population when compared to the
French, since they tend to have higher GERP scores (see Results),
which may impact upon the incidence of Mendelian diseases
under a homozygous recessive model.
It has previously been shown that there is proportionally more
deleterious variation in European populations after the out of
Africa expansion [14,15]. However, this process occurred over a
much longer timeframe and also relies on a long bottleneck to
explain the increase in deleterious variants in Europeans [14,15].
In French-Canadians we observe a similar increase of rare
deleterious variants but over a markedly short time frame.
Furthermore, since the French-Canadian population did not
undergo a long population bottleneck, the excess of deleterious
variants could be explained by a rapid expansion of the population
as well as other demographic factors such as subsequent regional
founder effects in Quebec. To test this we performed a number of
forward simulations incorporating selection and the demographic
history of Europe, as inferred in a recent study [14], followed by a
simple population bottleneck and rapid expansion in the French-
Canadian population, and a less extreme expansion in the French
Table 3. Estimated parameters for the distribution of fitness effects of new deleterious mutations.
Population NeE(s) (95% CI) b (95% CI) Nes (95% CI)
0–1 1–10 10–100 .100
French Canadian 13 (5,29) 0.24 (0.15,0.42) 0.42 (0.36,0.49) 0.29 (0.20,0.44) 0.27 (0.14,0.29) 0.02 (0.0,0.09)
French 105 (61,204) 0.15 (0.12,0.17) 0.40 (0.38,0.44) 0.16 (0.14,0.19) 0.22 (0.18,0.25) 0.21 (0.16,0.26)
European (EPG) 61 (16,4.86105) 0.29 (0.08,0.54) 0.23 (0.15,0.33) 0.22 (0.06,0.33) 0.36 (0.07,0.48) 0.19 (0.01,0.54)
European (PGA) 51(16,-.‘) 0.19 (0.04,0.32) 0.37(0.29,0.46) 0.20 (0.04,0.31) 0.27 (0.04,0.35) 0.15 (0.02,0.45)
European results are taken from Keightley et al [31]. The table shows estimates for the mean selective effect (NeE(s)), the shape parameter of the distribution of selective
effects (b) and the proportions of mutations falling into each group of selective effects.
doi:10.1371/journal.pgen.1003815.t003
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population (for details, see Materials and Methods). We modeled
population bottlenecks of varying sizes, performing 100 replicates
for each scenario, and then calculated the difference in the
proportion of variants with MAF,5% between the French and
French-Canadian populations (Table S6). The scenarios modeled
likely represent a simplified version of the actual demographic
history of the French and French-Canadian populations, however
we use them here to test differences between populations
undergoing different rates of expansion under selective constraint
after sharing a large proportion of demographic history. Under
these models, the largest increase in rare variants in French-
Canadians occurs when the population did not undergo a
bottleneck, showing differences as large as 5.23% across the 100
replicates, with an average shift of 1.09%. Furthermore, we also
observe on average an additional 8.32 deleterious alleles per
megabase (defined as having a negative selection coefficient) per
replicate segregating in the French-Canadian population com-
pared to the French population. For simulations including a
bottleneck, the biggest increase of rare variants in the French-
Canadian population occurs for a bottleneck of 75%, with
differences as large as 5.74% across the 100 replicates, an average
increase of 0.74% and an additional 5.86 deleterious alleles per
megabase per replicate in the French-Canadian population.
Although these simple models lead to an increase in the
proportion of rare variants in the French-Canadian population,
the shift observed in the empirical data, which shows an increase
of 9.8% of variants with MAF,5% in the French-Canadian
population compared to the French population when using the
same sample sizes (see above and Figure S1), is larger than that
generated by simulations; there are several possible explanations
for this. First, it may be that current tools are not able to accurately
model recent events such as a rapid population expansion. Second,
it is likely that a more complex demographic scenario is needed to
explain the size of the increase in rare variants in the French-
Canadian population, that may also include changes in selective
forces as a consequence of the reduced competition occurring
between a small number of founders. In fact, the French-Canadian
population is genetically stratified into subpopulations with
differentiated demographic histories [19,21,22]. Independent
settlements and expansions with partially reduced genetic
exchange across subpopulations, unequal contribution to the
current genetic pool, as well as some admixture with other
populations could have also contributed to the shift in the site
frequency spectrum. Consistent with these notions, a recent study
focusing on a specific sub-founding population within Quebec
presented evidence that individuals on the wave front of
colonization events have a heritable advantage and a higher
contribution to the current genetic pool [23]. In this study, we
have not focused on specific regions within the population and
have not tested this observation. However, our results do
demonstrate that the recent founding event and subsequent
colonization events may have had a substantial deleterious impact
across genomes. To a lesser extent, rare variants could also arise
from the inclusion of founders from different regions in France or
other European countries, which could be also related to the level
of genetic diversity in Quebec, similar to that reported for
European populations [21]. Similarly, the unequal sex ratio of the
Quebec settlers of more than ten times more men than women
[18], may also have contributed to a shift in the effective
population size and loss of heterozygosity. Finally, although there
is evidence of a population bottleneck in the French-Canadian
population, such as reduced levels of heterozygosity, given the
results of our simulations it seems unlikely that the bottleneck was
particularly strong.
In this study, we show that even in the case of two very close
populations that are separated by only 400 years approximately,
the differences in the landscape of genetic variation can be
substantial under particular demographic conditions. Rare vari-
ants are presumed to explain some of the missing heritability not
accounted for by common variants in genome wide association
analyses for complex disorders [33] as well as most of the rare
diseases. Furthermore, there is mounting evidence that coding rare
variants are contributing to complex traits [34]. The high number
of population private rare functional variants described in this
study constitutes a challenge for genetic association studies,
affecting the replicability and correlation of genetic risk factors
across human populations. Indeed, even from a relatively limited
number of French-Canadian chromosomes, we discovered a
substantial number of missense mutations that are not found on
the widely used Illumina exome-arrays built from SNPs ascer-
tained across a number of major sequencing studies. One third of
the missense SNPs we discovered from sequencing over one
hundred exomes are not found on these arrays, variation that
likely influences complex traits and disease phenotypes, but is
missing from analysis of disease risk. Although we understand from
population genetics that most variants will be rare, this observation
speaks to the need for continued sequencing of isolated or semi-
isolated populations. Beyond the particular case of the French-
Canadian population, this study highlights the importance of local
demographic events in shaping genetic variation, and the need for




This research has been approved by the CHU Sainte-Justine’s
ethical committee. Data was analyzed anonymously.
Samples
One hundred and fourteen French-Canadians were selected for
sequencing. French-Canadian samples are the healthy parents of
four disease cohorts (primary immunodeficiencies, acute lympho-
blastic leukemia, schizophrenia and autistic spectrum disorder)
recruited at the Sainte-Justine Hospital (Montreal). Additionally,
sequences from 30 French samples previously analyzed were
included in the study [24]. We used principal component analysis
to identify and remove the genetic outliers (see below).
Exome capture and sequencing
Exome capture was performed with the SureSelect Target
Enrichment System from Agilent Technologies optimized for
Applied Biosystems SOLiD sequencing, using the Agilent
SureSelect All Exome Kit (38 Mb) and the Human All Exon
50 Mb kit covering exons annotated in the consensus CCDS [35].
Analyses were performed considering the coding regions targeted
in the Agilent SureSelect All Exome Kit (38 Mb). Briefly, 3–5 mg
of DNA were sheared by sonication, 59 ends repaired, and the
resulting fragments were ligated to adaptors, which were then run
in size-select gels to select fragments of 150–250 bp in size. The
extracted DNA was amplified by PCR and hybridized to the
capture library containing the human exome. Hybridization was
performed in a solution at 65uC for a minimum of 24 hours,
followed by washing and capture of the hybridized DNA through
magnetic bead selection, PCR and purification. Quantification of
DNA libraries was performed using a Bioanalyzer and qPCR
instrument. Exome sequencing was performed using SOLiD 3
Plus and SOLiD 4 Systems (Applied Biosystems), following the
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manufacturer’s recommended protocols. Sequence reads were
aligned to the human genome reference sequence (hg18,
downloaded from http://genome.ucsc.edu) with BioScope, the
available mapping tool for the SOLiD technology. GATK
recalibration [36] was applied after mapping, PCR duplicates
removed with Picard (http://picard.sourceforge.net) and SNP
calling was performed using Samtools [37]. In total, 61 gigabases
of sequencing reads mapped to the reference genome, with an
average of 86% of the targeted regions being covered by at least
one sequencing read. Each individual had an average coverage of
17-fold (see supplementary material, Table S5). SNP annotation
was performed using the SeattleSeq Annotation tool (http://gvs.
gs.washington.edu/SeattleSeqAnnotation/). Variants from the
French population were generated from exome sequencing of
the same targeted exons using Illumina sequencing [24].
High quality dataset
Stringent variant calling criteria were applied to produce a high
quality dataset of both the French and French-Canadian
populations, including only variants that satisfy all of the following
conditions: (i) fall within the regions targeted by the Agilent
SureSelect exome capture kit, (ii) with SNP consensus or variant
quality of 30 or higher, (iii) with sequence coverage of 10-fold
depth or greater and (iv) in Hardy-Weinberg equilibrium (using a
stringent p-value of 0.001). Furthermore, variants were included
only if these criteria were met in at least 20 individuals in both the
French and French-Canadian populations. The average transi-
tion/transversion ratio for all the French and French-Canadian
samples in the coding variants was 3.32, as expected for exonic
sequences [38] and we detected no significant difference between
French and French-Canadian samples (3.38 and 3.30, respective-
ly). Similarly, frequencies of the twelve possible nucleotide changes
are similar between the two populations (Figure S8). For the
resampling analyses, we randomly choose thirty individuals from
the French-Canadian population and applied the same filters as
above.
Population structure analysis
In order to use the most genetically homogeneous group of
individuals in each population we performed principal component
analysis (PCA) for each population sample using SmartPCA as
implemented in the program eigenstrat [39]. First, PCA was
performed within each population including variants called in at
least 80% of the individuals in each population to avoid the effects
of missing values; these variants totaled 13,035 positions for the
French-Canadian population and 26,843 for the French popula-
tion. Significant PCs were inferred using the TW-statistic (p-
value,0.01) and outlier individuals were identified based on their
individual loading exceeding two standard deviations from the
mean of each significant axis. This analysis revealed five outlier
individuals in the French-Canadian population and none for the
French samples (Figure S9). Removing outlier individuals based on
population structure analysis of each population separately
resulted in the retention of 109 French-Canadian and 30 French
individuals for subsequent analyses. Next, we performed PCA
combining both populations, including only positions called in at
least 80% of the combined samples, and only individuals with
missing data less than 1%. This represented a total of 4,588 SNPs
in 89 samples. We find no obvious differences between the two
populations (Figure S9), although the French-Canadian popula-
tion seems to show a slightly lower level of diversity and represents
only a subset of the total genetic variation in the French
population. The joint frequency spectrum of genetic variation
was represented using the dadi software [40].
SNP validation
We performed a number of validation procedures to check the
quality of our data. First, we performed Sanger sequencing on a
total of 113 heterozygous calls detected in the individuals included
in this study (89% of the 97 variants have MAF,5% and 54%
were singletons). In total we confirmed 109 calls, giving a false
positive rate of 3.5%. This figure probably represents an upper
bound, since the variants selected for validation are enriched for
rare variants which are known to be more prone to sequencing
errors [41]. Second, we sequenced the offspring of 16 individuals
from the French-Canadian population, using the same protocols
and filtering steps as in the parents, in order to confirm the
presence of certain alleles in the population. Thus, to check the
false positive rate for variants that are likely to contain the most
errors (singletons), we isolated any positions in the parents that
were singletons in our population and then checked to see if the
variant is called in the child, only including the position if the same
quality filters were met in the offspring (variant quality.30,
coverage.10). Under normal patterns of Mendelian inheritance
we expect 50% of singletons to be inherited by the child. Overall,
we observe 4,666 singletons across the 16 individuals, 2,328 of
which are present in the offspring (49.89%), representing a false
positive rate for singletons of ,0.2%.
Third, we also tested the quality of our data by comparing DNA
and RNA sequences for three French-Canadian individuals using
the same high quality filtering criteria in both datasets (consensus
or variant quality greater than 30, coverage greater than 10). For
RNA sequencing, RNA was enzymatically fragmented, and cDNA
generated by reverse transcription from adaptors ligated to ends of
the RNA molecule. Then, the cDNA was amplified using primers
complementary to adaptors and purified. Sequencing was
performed in a single SOLiD slide containing barcoded samples.
Sequence reads were aligned to the human genome reference
sequence (hg18, downloaded from http://genome.ucsc.edu) with
SOLiD’s BioScope mapping tool. Recalibration was performed
with GATK [36], and PCR duplicates were removed with Picard
(http://picard.sourceforge.net). SNP calling was performed using
Samtools [37]. As differences may exist between DNA and RNA
as a consequence of RNA editing [42–45] and allelic expression
[46], for positions that are heterozygous in DNA, we considered a
site as successfully validated if at least one read was present in
RNA for both alleles; we confirm 474 of 506 sites. Since it is
known that approximately 28% of genes show greater than a 4-
fold difference in the expression of two alleles in RNA [46], it is
likely that some differences between DNA and RNA are driven by
allelic specific expression. Indeed, 5 out of the 32 sites that fail
validation in one individual show evidence for being heterozygote
(displaying at least one read from each allele) in the RNA of at
least one of the other two individuals that were sequenced.
Differences between DNA and RNA at heterozygous sites are not
significantly enriched for rare variants; only 5 out of 32 sites that
fail validation have MAF,5% (variants with MAF,5%, 5/66 not
validated, p = 0.92). Furthermore, we also considered sites that
contained homozygous non-reference alleles in DNA sequences
and then checked the corresponding position in RNA. All 242
positions were validated, further confirming the quality of the data.
Finally, to consider the quality of common variants, we
compared the genotype frequencies at polymorphic sites obtained
from our exome sequencing that overlapped with data from 521
French-Canadian individuals that were genotyped on Illumina’s
Omni 2.5M arrays. In each case we compared the number of
homozygous reference, homozygous alternative and heterozygous
calls in our exome data with the same number of randomly
sampled individuals from the chip data. In total, 23,231 sites were
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overlapping, 99.94% of which were not significantly different
between exome sequencing and array data (p.0.05, after
Bonferroni correction).
Selection coefficient and fitness effect analysis
To estimate the strength of purifying selection in the French
and French-Canadian populations we applied two methods. First,
we used prfreq, a program that uses Poisson random fields [14] to
estimate the maximum likelihood values for different scenarios
given an observed site frequency spectrum (SFS). For the French
and French-Canadian populations, we projected the SFS down to
60 alleles by randomly sampling individuals from the French-
Canadian population and including only sites with 0% missing
data. The ancestral allele was inferred from the homologous
chimpanzee sequence obtained from Seattleseq annotation
(http://gvs.gs.washington.edu/SeattleSeqAnnotation/) and since
mutation rates vary across the genome as a function of
neighbouring nucleotides [47], we corrected for the uncertainty
of the ancestral sequence following the method of Hernandez et al
[48]. Maximum likelihood values for each scenario were obtained
with a multinomial calculation that estimates the probability of
each SNP segregating at a given derived allele frequency. P-
values associated with various demographic and selective models
were estimated using likelihood-ratio tests. Demographic param-
eters were inferred from the site frequency spectrum of
synonymous variants comparing three scenarios: a stationary
population, contraction/expansion, and a population bottleneck
and expansion (Tables S2 and S3). Finally, the selective
parameters were obtained by comparing the likelihood of the
missense SFS using the demographic model inferred from
synonymous variants (see above) to the likelihood for the same
demographic model incorporating a selection parameter
(c=2Ne(s)). To compare the c values estimated in the French
and French-Canadian populations we compared the likelihoods
estimated in each case with the likelihoods computed using the c
values from the other population.
Second, to calculate the distribution of fitness effects associated
with mutations occurring in the French and French-Canadian
populations we used the DFE-alpha software [31] (http://
homepages.ed.ac.uk/eang33/). To construct the unfolded site
frequency spectrums for the two populations we included variants
and sites in the targeted region in which at least 30 and 90
individuals passed the high quality filters for the French and
French-Canadian populations respectively. These numbers were
chosen to reduce the amount of missing data at each site, whilst
retaining the majority of polymorphic sites for analysis. We then
counted the number of sites that had zero to 180 derived alleles in
the French-Canadian population, where derived alleles represent
sites that have diverged from chimpanzee. The same approach
was applied for the French population using 60 chromosomes.
For the French-Canadian population, ninety individuals were
sampled randomly without replacement at sites where the
number of alleles passing quality filters exceeded 180. Derived
alleles were inferred from chimpanzee sequences and human and
chimpanzee pairwise alignments were downloaded from the
UCSC website (http://hgdownload.cse.ucsc.edu/downloads). As
in the original DFE analysis [31], intronic sites served as the
neutral standard, the distribution of fitness effects was fit to zero-
fold degenerate sites and any sites that were part of a CpG
dinucleotide were removed. Confidence intervals were generated
by bootstrapping; sites were selected randomly across the site
frequency spectrum with replacement to generate 100 new
datasets for each population.
Replication datasets
To replicate the major findings of this study we analyzed data
from a cohort of fifty French-Canadian individuals sequenced on
the Illumina platform representing the unaffected parents from
different disease projects (developmental delay and fetal malfor-
mations). Exomes were captured from 3 mg of blood genomic
DNA, using the Agilent SureSelect Human All Exon Capture kit
(V3 and V4; Mississauga, ON), and sequenced paired end using
the Illumina Hi2000seq technology. Raw sequencing data was
processed using the same pipeline and filtering process as
described above, including only those sites that are sequenced in
all datasets. PCA was performed as before, taking SNPs with
MAF.5% and missing data,5% - zero outliers were removed
(Figure S10). For the CEU population, we obtained BAM files for
35 individuals from the 1000 Genomes Project ftp site (ftp://ftp-
trace.ncbi.nih.gov/1000genomes/ftp/) sequenced on the SOLiD
platform and applied the same pipeline and filters as detailed
above.
Simulations
To test for an increase in rare variants in the French-Canadian
population we simulated a number of demographic scenarios
under selection using the forward simulator SFS_code [49]. First,
we implemented timing and population size scaling for the
European demographic history, as detailed in the SFS_code
documentation (http://sfscode.sourceforge.net/SFS_CODE_doc.
pdf, figure 2, model taken from [14]). This model includes an
initial burn-in period with a population size of 7,895, followed by a
bottleneck at time zero to a population size of 5,699. Following
this, the population remains at constant size for 7,703 generations
before an instantaneous growth to 30,030, which remains for a
further 874 generations. We scaled this model using an ancestral
population size of 1,000. Then, we simulated a population split
and a bottleneck of 50%, 75% and 100% (no bottleneck) for one of
the populations to represent the founding of Quebec, scaled using
the initial population size to occur twenty generations ago. This
was then followed by exponential growth over twenty generations
in the European and Quebec populations to increase their size by
3 and 600 respectively (as documented in historical records), using
100 replicates for each scenario. In total, we simulated 360
unlinked genes per replicate, each consisting of five 400 bp exons
separated by introns of size 2 kb (similar to the average exon and
intron sizes documented in [50]). We used a mutation rate per site
of 1.561028 and an average recombination rate of half this value.
We ignored positive selection since it is likely to be rare and used
an average selection coefficient of 20.03, as inferred in [14],
sampled from a gamma distribution. In each replicate and for each
population, we selected 100 individuals and then compared the
proportion of variants with MAF,5%. The results of these
simulations are shown in Table S6.
Supporting Information
Figure S1 Site frequency spectrum for French and French-
Canadian populations using the same sample size. Thirty
individuals were selected at random from the French-Canadian
population and for both populations only sites with no missing
data are considered.
(PDF)
Figure S2 Tajima’s D values in the French and the French-
Canadian populations. Each dot represents the value for each gene
and the least squares regression line is shown in red.
(PDF)
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Figure S3 Site frequency spectrum for the synonymous,
missense and nonsense variants in the French-Canadian popula-
tion.
(PDF)
Figure S4 Percentage of shared and private variants between the
French (N= 30) and the French-Canadian populations (N= 109)
in this study.
(PDF)
Figure S5 Observed and expected folded site frequency
spectrum using prfreq. Observed and expected site frequency
distributions for the synonymous SNPs in the French population
(A), synonymous SNPs in the French-Canadian population (B),
nonsynonymous SNPs in the French Population (C), and
nonsynonymous SNPs in the French-Canadian population (D).
Expected distributions have been obtained with a neutral model
not including demography, a model with demography, and for the
nonsynonymous variants a model with demography and selection
is also included (see parameters in Table S3).
(PDF)
Figure S6 A) Site frequency spectrum in the French and the
French-Canadian populations using Illumina datasets for the
synonymous variants; B) Site frequency spectrum in the French
and the French-Canadian populations using Illumina datasets for
the missense variants; C) Site frequency spectrum in the CEU and
the French-Canadian populations using SOLiD datasets for the
synonymous variants; D) Site frequency spectrum in the CEU and
the French-Canadian populations using SOLiD datasets for the
missense variants.
(PDF)
Figure S7 Distributions of the average GERP scores at
functional sites per individual in the French and the French-
Canadian populations. GERP scores are averaged per individual
by using only sites at which each individual carries the minor
allele.
(PDF)
Figure S8 The proportions of the twelve possible nucleotide
changes in each population.
(PDF)
Figure S9 Principal Component Analysis with A) the 114
French-Canadian samples; B) the 109 French-Canadian samples
after removing five genetic outliers; C) the 30 French samples (no
genetic outliers were detected); D) the 109 French-Canadian and
the 30 French samples.
(PDF)
Figure S10 Principal Component Analysis of the 50 French
Canadians sequenced using the Illumina technology.
(PDF)
Table S1 Total number of SNPs in the 38 Mb targeted regions
in the French and the French-Canadian populations.
(DOCX)
Table S2 prfreq maximum likelihood estimates of neutral,
demographic and selective models for the French Population.
(DOCX)
Table S3 prfreq maximum likelihood estimates of neutral,
demographic and selective models for the French Population.
(DOCX)
Table S4 Summary values for tests for rare and damaging
variants in the French and French-Canadian populations. Rare
variants are defined as those with a minor allele frequency less that
5%.
(DOCX)
Table S5 Sequencing statistics for the 144 samples included in
this study.
(DOCX)
Table S6 Results from forward simulations modeling the
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